Anavex Life Sciences Corp. (0HFR.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
12.98+1.25 (+10.67%)
At close: 5:35PM GMT
| Previous close | 11.73 |
| Open | 13.22 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 12.98 - 13.22 |
| 52-week range | 12.98 - 13.22 |
| Volume | 449 |
| Avg. volume | N/A |
| Market cap | N/A |
| Beta (5Y monthly) | 0.50 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.46 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Motley Fool
Anavex Life Sciences (AVXL) Q1 2021 Earnings Call Transcript
The call will also be available for replay on Anavex's website at www.anavex.com. With us today is Dr. Christopher Missling, president and chief executive officer; and Sandra Boenisch, principal financial officer.
- Zacks
Deciphera (DCPH) Reports Narrower-Than-Expected Q4 Loss
Deciphera Pharmaceuticals (DCPH) reports narrower-than-expected loss. Nonetheless, sales marginally surpass estimates for the fourth quarter of 2020.
- Simply Wall St.
We're Not Very Worried About Anavex Life Sciences' (NASDAQ:AVXL) Cash Burn Rate
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
© 2021 Verizon Media. All rights reserved.
